Democratic AGs File Amicus Brief Supporting Drug Pricing Transparency Law

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • A group of 21 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the Ninth Circuit supporting Oregon in its defense of H.B. 4005, which requires pharmaceutical manufacturers to report certain information about specific new prescription drugs and historical information about pricing for existing drugs.
  • The U.S. District Court for the District of Oregon had granted summary judgment in favor of Pharmaceutical Research and Manufacturers Association—a trade association of U.S. drug manufacturers—on its First Amendment claim, and Oregon appealed.
  • In the brief, the AGs argue that drug transparency laws like H.B. 4005 are important in states’ efforts to lower costs of prescription drugs.
  • The AGs ask the Ninth Circuit to reverse the district court’s grant of summary judgment.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide